Physician profile
Eva Henry
NPI 1801810312
$100,705.37
in general payments reported to CMS, 2019-2025
18 companies · $9,741 in 2025
The $9,741 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $24K · 2021: $26K · 2022: $12K · 2023: $15K · 2024: $13K · 2025: $9,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Food and Beverage: $3,264 · Travel and Lodging: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,662.50 |
| Food and Beverage | $3,264.04 |
| Travel and Lodging | $1,463.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $66,342.40 | 2021-2025 | |
| Allergan, INC. | $29,968.47 | 2019-2021 | |
| Medtronic, INC. | $1,644.09 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Percept Pc Brainsense |
| Abbott Laboratories | $595.52 | 2024 | Infinity |
| Pfizer INC. | $556.74 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $439.24 | 2019-2022 | |
| Amgen INC. | $200.61 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $192.04 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $155.36 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $148.09 | 2021 | |
| Axsome Therapeutics, INC. | $126.76 | 2025 | Symbravo |
| Lundbeck LLC | $120.05 | 2021-2022 | |
| Biogen, INC. | $106.84 | 2020-2022 | |
| Inspire Medical Systems, INC. | $27.27 | 2023 | Inspire |
| Tanabe Pharma America, INC. | $23.90 | 2025 | Radicava |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $21.77 | 2023 | Uplizna |
| Lilly USA, LLC | $18.16 | 2019 | |
| Amneal Pharmaceuticals LLC | $18.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.